EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Survival analysis of distant prostate cancer by decade (1973-1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program Registry: Has outcome improved? (United States)



Survival analysis of distant prostate cancer by decade (1973-1997) in the Detroit Metropolitan Surveillance, Epidemiology and End Results (SEER) Program Registry: Has outcome improved? (United States)



Cancer Causes and Control 14(7): 681-685



Objective: The purpose of this study is to examine differences in survival after diagnosis with distant stage prostate cancer by decade of diagnosis. Methods: Subjects are 3337 Caucasian and 1947 African-American men with newly diagnosed primary distant stage prostate cancer between 1973 and 1997, with follow-up through 2001, from the Detroit SEER registry. The proportion of men within each category of each variable of interest is calculated. Relative survival is used to examine survival patterns over time. Kaplan-Meier and Cox proportional hazard models are also used to examine the relationship between decade of diagnosis and survival between short term (ltoreq24 months) and long term (>24 months) survivors. Results: Relative survival has increased over the past three decades although this trend is not statistically significant. Relative survival is similar by race and decreases with increasing grade of tumor. Survival for men living ltoreq24 months after diagnosis is similar over time. However, for men living >24 months after diagnosis, there is a significant difference over time (p < 0.0001). Conclusion(s): In general, relative survival has been improving over the past three decades. However, it is the long term survivors (>24 months) that are the primary contributors to this difference in survival by decade of diagnosis.

(PDF emailed within 0-6 h: $19.90)

Accession: 011432139

Download citation: RISBibTeXText

PMID: 14575366

DOI: 10.1023/a:1025675303370



Related references

Survival analysis of distant prostate cancer by decade in the Detroit Metropolitan Surveillance, Epidemiology and End Results Program Registry Has outcome improved?. Cancer Causes & Control 14(7): 681-685, September, 2003

Time trends in the epidemiology of newly diagnosed stage IV prostate cancer in the United States: An analysis of data from the Surveillance, Epidemiology, and End Results (SEER) Program (1988 - 2003). Journal of Clinical Oncology 26(15_suppl): 5059-5059, 2016

Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma. Journal of Registry Management 39(4): 158-166, 2014

Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry. International Journal of Radiation Oncology, Biology, Physics 72(4): 1128-1133, 2008

Pre-operative radiation is associated with improved survival in patients with resectable pancreatic cancer: Analysis of data from the surveillance, epidemiology, and end results (SEER) registry. International Journal of Radiation Oncology*Biology*Physics 69(3-supp-S): 0-0, 2007

Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. JAMA Oncology 1(1): 88-96, 2016

Risk of brain metastases in patients with nonmetastatic lung cancer: Analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data. Cancer 122(12): 1921-1927, 2016

Trends in brain cancer incidence and survival in the United States: Surveillance, Epidemiology, and End Results Program, 1973 to 2001. Neurosurgical Focus 20(4): E1-E1, 2006

Building the infrastructure for nationwide cancer surveillance and control: A comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) Program (United States). Cancer Causes and Control 14(2): 175-193, 2003

The effect of age, race, and treatment on the survival of men with prostate cancer identified through the 1973-1987 seer database in metropolitan Detroit. Journal of Urology 151(5 SUPPL ): 507A, 1994

How representative are the surveillance, epidemiology, and end results (SEER) program cancer data of the United States?. Cancer Causes & Control 15(10): 1027-1034, 2005

How representative are the surveillance, epidemiology, and end results (SEER) Program cancer data of the United States?. Cancer Causes and Control 15(10): 1027-1034, 2004

The effect of marital status on survival in late-stage cancer patients: an analysis based on surveillance, epidemiology, and end results (SEER) data, in the United States. International Journal of Behavioral Medicine 6(2): 150-176, 2005

Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program. Urology 75(6): 1396-1404, 2010

Survival of patients with breast cancer tumors 1 cm or less. Analysis of the Surveillance, Epidemiology and End Results (SEER) Registry. Journal of Clinical Oncology 23(16_suppl): 656-656, 2016